Claus Hancke, M.D.

 

Specialist in General Medicine
Institute for Orthomolecular Medicine
Lyngby, Denmark

 

 

Telephone:  +45 88 09 00

Fax:  +45 88 09 47

Email: ch@iom.dk

Address:
Claus Hancke, M.D.
Institute for Orthomolecular Medicine
Lyngby Hovedgade 37
DK-2800-Lyngby
Denmark

www.iom.dk


CERTIFICATIONS

Student exam. Mathematics/Physics, Gentofte / Copenhagen 1966.
Medical License: Jan.1974 from University of Copenhagen.
Physicians License: 1974.
License for General Practice: 1976.
Emergency Medicine: 1977.
Aviation Medicine: 1977.
ABCT Diplomate: 1990.
Specialist in General Medicine: 1994.


Educational Occupations (as junior physician)

1974 Dermatology: Finsen Institute, Copenhagen, Denmark
1974 Surgery: Sundby Hospital, Copenhagen, Denmark
1975-76 Internal Medicine: Lycksele Lasarett, Sweden
1976 Psyciatrics: Umedalen, Umeå, Sweden
1976 Gyn./Obstetrics: Lycksele Lasarett, Sweden
1977 General Medicine: Rana Legesenter, Mo i Rana, Norway
1977 General Medicine: Lycksele Distriktslaekarcentral, Sweden
1977-78 Aviation Medicine: Vaerloese Air Base, Copenhagen, Denmark
1978 Rheumatology: Esboenderup Sygehus, North Sealand, Denmark

Professional Occupations

1977 Works Doctor, Burmeister & Wain Shipyard, Copenhagen
1982-86 Medical Consultant, County of Helsinge, North Sealand, Denmark
1986-1996 Army Medical Offc, HJV District North Sealand, Denmark
1997-2007 Army Medical Offc, HJV Region Copenhagen and North Sealand
1979-1988 General Practice (publ), Helsinge, North Sealand, Denmark
1988–Present Orthomolecular Practice, Kgs.Lyngby, Copenhagen

SPECIAL COURSES

1976    Theoretical Medicine
1977    Emergency Medicine
1977    Aviation Medicine
1979    Column Diseases
1980    Diabetes
1981    Paediatrics
1981    Mycology
1982    Column Diseases
1983    Oncology
1983    Allergology
1984    Pain. Mechanism and coping
1984    Pulmonary Diseases (Teacher)
1985    Cardiology
1985    Endocrinology
1986    Preventive Medicine
1987    Lipid Metabolism
1987    Chelation therapy
1988    Chelation therapy
1990    Chelation therapy
1992   Chelation therapy
1993    Chelation therapy
1994    Chelation therapy
1995    Chelation therapy
1997    Chelation therapy
1997    Anti-Aging Medicine
1998    Anti-Aging Medicine
1998    Anti-Aging Medicine
1999    Chelation Therapy
2000    Mercury toxicity
2000    Anti-Aging Medicine
2000    Immunology
2001    Chelation Therapy
2001    Chelation Therapy
2002    Nutrition
2003    Nutrition
2003    Chelation Therapy
2004    Metal toxicology
2004    Nutrition
2005    Heavy metal toxicology
2005    Nutrition
2005    Endocrinologi
2006    I.V. therapies
2007    Heavy metal toxicology
2007    Chelation Therapy
2008    IV Therapies
2009    Detoxification
2011    Clinical Nutrition
2012    Oxidative Medicine


CONFERENCES

1986    Austria: General Medicine
1987    USA: Cellular Immunity, Damage and Repair
1988    USA: Orthomolecular Medicine
1990    USA: Immune Function and Dysfunction
1990    USA: Free Radicals in Health and Disease
1991    USA: Arteriosclerosis
1991    Italy: Free Radicals and Antioxidants
1992    USA: Chronic Fatigue
1992    Germany: Chelation Therapy (lecturer)
1993    USA: Duality of Oxygen in Health and Disease
1994    USA: Science in Clinical Practice
1994    USA: Lifestyle Medicine
1995    USA: Trends in Gender Related Healths Issues
1995    USA: Aging: Reducing, Reversing, Coping
1996    USA: Medical Challenges of the Next Millennium
1997    USA: Disorders in the Immune System
1997    Denmark: Health-Trends 2000, Longevity, (organiser and moderator)
1997    USA: Non-Pharmacological Intervention in Disease Managemet
1998    Canada: Nutrition Medicine today
1998    USA: Nutritional intervention in Cancer Prevention and Therapy
1999    USA: Exploring the Functions of the Brain: Solutions for Tomrorrow
1999    Denmark: Health-Trends 2000, Lifestyle Diseases, (organizer, moderator)
1999    USA: Cutting Edge Medicine. Optimizing Patient Outcomes
2000    USA: Medical Challenges for the Family
2000    USA: Infection, Inflammation, Immunity
2001    USA: New Advances in Complementary Medicine
2001    USA: Integrative Medicine
2002    USA: Integrative Medicine
2002    USA: Integrative Medicine
2002    London: 3rd International CoQ10 conference
2001    USA: New Advances in Complementary Medicine
2002    USA: New Advances in Complementary Medicine
2002    USA: New Advances in Complementary Medicine
2002    Denmark: Health-Trends 2002, Lifestyle Diseases, (organizer, moderator)
2002    England: 3. International Coenzym Q10 conference
2003    USA: Cancer. Complementary and conventional therapy
2003    USA : Neurological Diseases. Genetical- and Environmental Impact
2004    Germany:   2nd European Conf. of Advanced Clinical Metal Toxicology
2004    USA: Minerals, Metals and Metabolism
2004    USA: Emerging Concepts in Immunology
2005    USA: 2nd International Congress of Complementary Cancer Therapy
2005    USA: Menopause, Andropause: Power in Transition
2005    USA: New Research in Integrative Medicine
2006    USA: Chronic Infections, Lyme, Hidden Infections
2006    USA: Integrative Therapies for Neurological Disorders
2007    USA: Orthomolecular Medicine in the Future Patient Care
2007    USA: Integrative Medicine, Science and Clinical Practice
2008    USA: CAM Approaches to Cardiovascular Disease & Inflammation
2008    USA: Frontiers of Integrative Oncology
2009    USA: Detoxification
2011    USA: New Research in Integrative Medicine. Inflammation, Vit-D
2012    USA: Oxidative Medicine


PROFESSIONAL SOCIETIES

Danish Medical Association, 1974-
The Medical Society of Copenhagen, 1974-
Danish Society of General Medicine. 1979-
Danish Society of Manual Medicine, 1979-2002
Danish Society of Military Medicine, 1986-
American College for Advancement in Medicine, 1987-; Liaison/DK 1991-; Fellow 1998
American Board of Chelation Therapy, 1990-
International Board of Chelation Therapy, 1994-
Danish Society of Othomolecular Medicine, 1991-; Chair 1991-2002
American Preventive Medical Association, 1992-
Scandinavian Board of Clinical Metal Toxicology, 1995-; Chair 1995-
International Society for Orthomolecular Medicine, 1997-
Danish Society of  Phyto-Medicine, 1999-
International Board of Chelation Therapy, 1994-
International Board of Clinical Metal Toxicology, 2004-


LECTURES

Emergency Medicine
Aviation Medicine
Free Radicals and Antioxidants
Preventive Medicine
Orthomolecular Medicine
Chelation Therapy
Redox treatment of cancer
Anti Aging
Human Nutrition
Medical Ethics
Health Politics


OTHER ASSIGNMENTS

1996-Present Member of the Danish State Medical Advisory Board concerning Alternative Medicine
1996-2000 Member of the editorial board of Journal of Advancement in Medicine (Human Sciences Press, New York).
2000-2004 Member of the editorial board of Clinical Practise of Alternative Medicine
2001-2003 Member of the editorial board of  Nordisk Tidsskrift for Biologisk Medisin
2002-2011 Chairman of “Vital Counsil”

BIOGRAPHY

“The Descendants from Lars Hancke”. Gunnar Hancke 1983.

“The Danish Medical Society”, 15., 16. and 17.edition, Copenhagen 1982, 1993, 2000.


PUBLICATIONS

*   =   Peer Reviewed Medical Journal.

01)* Hancke C. Curettage af vorter. Journal of the Danish Medical Association           (Ugeskrift for Læger) 1974;136:1127-1131.
02)* Hansen JG, Knudsen JM, Hancke C. Alment praktiserende laeger og speciallaeger ser forskelligt på  det – eller ser noget forskelligt. J Danish Med Ass 1983;145:1331-1332.
03)* Hornslet A, Hoffmann S, Backer P, Bentzen K, Clausen S, Hancke C. Hurtigdiagnostik af akutte luftvejsinfektioner i almen praksis. J Danish Med Ass 1988;150:1271-1274.
04)* Ahn NC, Hancke C. EDTA-behandling af arteriosclerose. J Danish Med Ass 1989;151:2599.
05)* Hancke C. Immune Function and Dysfunction:Scientific Perspectives and            Clinical Applications. J Danish Med Ass 1990;152:2183.
06) Hancke C. Spild af tid og penge på forkert undersøgelse. Nyhedsinformation for Social- Sygehus- og Sundhedsvæsen 1990;5:4.
07)* Hancke C. Free Radicals: Understanding and Managing Their Impact on Health and Disease. J Danish Med Ass 1991;153:521.
08) Hancke C. EDTA virker. Teori & Terapi 1991;2:21.
09)* Hancke C. Lægestandens Koncensus. J Danish Med Ass 1991;153:3578.
10) Hancke C. Frie radikaler / antioxydanter: Kontrast mellem viden og brug. Non-pharm 1991;2/5:3.
11)* Flytlie K, Hancke C. Arteriosclerosis/Atherosclerosis: Assessment, Management, Reversal, Prevention. J Danish Med Ass 1992;154:1285.
12) Hancke C. EDTA igen. NaturMedicin 1992;6/4:1-2.
13)* Hancke C, Flytlie K. Manipulation med EDTA. J Danish Med Ass             1992;154:2213.
14)* Hancke C. EDTA som alternativ. J Danish Med Ass 1993;155:270.
15)* Flytlie K, Hancke C. EDTA Manipulated. Journal of Advancement in Medicine 1993;6:53-56(13).
16)* Flytlie K, Hancke C. Rezidiv- und Metastasen-profylaxe. J Danish Med Ass 1993;155:654.
17)* Hancke C, Flytlie K. Benefits of EDTA Chelation Therapy in Arteriosclerosis: A Retrospective Study of 470 Patients. Journal of Advancement in Medicine 1993;6/3:161-171.
18)* Hancke C. The Medical Consensus. Journal of Advancement in medicine 1993;6/3:193-194(9).
19) Hancke C. Myterne om det bedste sundhedsvæsen. Berl.Tid.21.01-94:9.
20) Hancke C. Må vi nu ikke spise gulerødder mere? Mit Helbred.1994;25:11
21) Hancke C. Det syge væsen. Mit Helbred.1994;26:14-15.
22)* Hancke C. Vor træske stand. J Danish Med Ass 1994;156:5559.
23) Hancke C. Fri os for et Jernhelbred. Mit Helbred.1994;27:6-7.
24) Hancke C. Spis trygt dit blødkogte æg. Mit Helbred.1994;28:24-25.
25) Hancke C. Danish study of EDTA Chelation Reviewed by Committee on Scientific Dishonesty. Townsend Letter for Doctors 1994;Nov:1218-1223.
26) Hancke C. Oh hellige videnskab. Mit Helbred.1995;29:12-13.
27)* Feddersen S, Flytlie K, Hancke C. EDTA – En medicinsk løsning på et kirurgisk problem. J Danish Med Ass 1995;157:1224-1225.
28) Hancke C. Hvem tager håbet fra hvem? Mit Helbred.1995;30:26-27.
29)* Hancke C. G-ordningens farer. J Danish Med Ass 1995;157:1556.
30)* Hancke C. O Sancta Science or Simplicitas. Journal of Advancement in medicine 1995;8:201-3.(26).
31) Hancke C. Det ligner mad. Mit Helbred.1995;31:24-25.
32)* Hancke C. EDTA Manipulated. Journal of Advancement in medicine 1995;8/1:67-68.
33)* Hancke C. Nypuritanisme eller faglig kamp. J Danish Med Ass 1995;157:3070-1.
34) Hancke C. Cognitiv dissonans. Mit Helbred.1995;32:26-27.
35)* Chappell LT, Miranda R, Hancke C, Frackelton JP, Carter JP. EDTA chelation treatment for peripheral vascular disease. J Internal Medicine 1995;237:429-430.
36) Hancke C. Sundhedsvæsenet-et urørligt offentligt gebet. Mit Helbred. 1995;33:14-15.
37) Hancke C. Patientforeninger eller lamperøg? Mit Helbred.1995;34:14-15.
38)* Hancke C. Er vor art truet. J Danish Med Ass 1995;157/48:6756-8.
39) Hancke C. EDTA.Gamle fejl i fin ny emballage. Mit Helbred.1995;35:6-7.
40) Hancke C. Orthomolekylær medicin. Det 21.århundredes lægekunst. Mit Helbred.1995;36:15-16.
41) Hancke C. Spontan helbredelse. Mit Helbred.1996;1:6-7.
42) Hancke C. Der er vist nogen, der har mistet overblikket. Mit Helbred.1996;1:20-1.
43) Hancke C. Vær på vagt over for sidste nyt i sundhedsråd. Berl.Tid.12/3-96.
44) Hancke C. Ny stænkelap-sag. Mit Helbred. 1996; 2: 12-3.
45) Hancke C. Som man råber i skoven. Mit Helbred. 1996; 3:12.
46) Hancke C. Nye ideer til lægerne. Politiken.18/5-96;2.sek.3.
47) Hancke C. Lægevidenskab eller lægekunst. Mit Helbred. 1996;4:6-7.
48) Hancke C. Yam.(Osteoporosis). Mit Helbred. 1996;5:6-7.
49) Hancke C. Ligemageriets pris er middelmådighed.Mit Helbred.1996; 6:14-5.
50) Hancke C. Hvorfor taler vi om kræftens gåde? Mit Helbred.1996; 7:10-12.
51) Hancke C. Lad os få ODA i stedet for RDA og ADT. Mit Helbred.1997;1: 2-3 (Editorial).
52)* Feddersen S, Flytlie K, Hancke C. EDTA-chelation. En medicinsk behand-ling og et kirurgisk problem. J Danish Med Ass 1997;159/21:3196-7.
53) Hancke C. Lægelige kostråd tages med et gran salt. Diætisten 1998;6/32:22-25.
54) Hancke C. Medicinsk kelering – ekologisk medicin på cellnivå. Näringsråd och Näringsrön (Götheborg). 1997;2/6:6-7.
55) Hancke C. Må vi nu ikke spise appelsiner mere? Mit Helbred.1998;3:6.
56)* Gad P, Hancke C. Alternative læger findes ikke. J Danish Med Ass 1999;161/40:5584-5586.
57) Hancke C. Sundhedsvæsenets fremtid er en blind vej. Mit Helbred.1999;7/8:61-61.
58)* Hancke C. The Long-term Effect of Chelation Therapy: A 6- to 12-year Follow up of a 1993 EDTA Study. Clin Pract Alt Med spring 2000, 1(3):158-163.
59)* Hancke C. Korrespondance. J Danish Med Ass 2001; 163/15:2172.
60) Hancke C. De rette molekylers medicin. Dagens Medicin 290301.
61) Hancke C. Får vi vitaminer og mineraler nok i en dansk normalkost? Lægemagasinet for Praktiserende Læger. 2001;6:18-19.
62) Hancke C. EDTA-kelering. Kliniska erfarenheter av kärlsjukdomer. Näringsråd och Näringsrön 2001;6(6):1-4.
63)* Hancke C. Magnesium-EDTA-chelationbehandling. Praktikus, 1. november, 2002.
64)* Hancke C. Third Conference of the International Coenzyme Q10 Association. J Danish Med Ass 2003;165/8:816-7.
65)* Andersen P, Hancke C. Mødereferat, USA. J Danish Med Ass 2003;165/35: 3330-1.
66)* Hancke C. Kosttilskud bør tages alvorligt. J Danish Med Ass 2003;165/39:3747.
67)* Hancke C. Magnesium-EDTA chelationsbehandling. Fremtidens first choice ved arteriosclerose. Praktikus 2003;160:56-7.
68) Skovgaard L. Lægekunst i det 21.århundrede. Hovedland 2003, ISBN: 8777396707:19-33. Orthomolekylær Medicin.
69)* Chappell LT, Shukla R, Hancke C et al. Subsequent Cardiac and Stroke Events in Patients with Known Vascular Disease Treated with EDTA Chelation Therapy.  Evid Based Integrative Med 2005;2(1): 27-35.
70) Skovgaard L. Sund Skepsis. Hovedland 2006, ISBN:8777398564:10-25. Antibiotika.
71) DSOM homage ”20 år mod strømmen”. Editor and article. 2009. Bording.
72) Bidsted O. Sundhedsvæsen eller Medicinindustri. Klitrosen 2010, ISBN:87-92041-14-0. ”Kættersk behandling af Åreforkalning.”
73) Skovgaard L. Sund Skepsis og Sund Fornuft. 2010, ISBN:978-87-7070-165-5. Antibiotika.